DaVita
DVA
#1468
Rank
C$21.60 B
Marketcap
C$336.53
Share price
0.51%
Change (1 day)
76.29%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): C$15.15

According to DaVita's latest financial reports the company's current EPS (TTM) is C$15.42. In 2025 the company made an earnings per share (EPS) of C$14.19 a decrease over its 2024 EPS that were of C$15.46.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$15.156.8%
2025C$14.19-8.25%
2024C$15.4644.94%
2023C$10.6727.26%
2022C$8.38-35.56%
2021C$13.0144.1%
2020C$9.0319.7%
2019C$7.54540.48%
2018C$1.18-76.07%
2017C$4.92-19.31%
2016C$6.10242.52%
2015C$1.78-62.87%
2014C$4.7913.43%
2013C$4.238.45%
2012C$3.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$34.08 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$15.92 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$27.18 76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.90-81.20%๐Ÿ‡บ๐Ÿ‡ธ USA